Ilness perception in end stage renal disease patients treated with haemodialysis (HD) and peritoneal dialysis (PD)

被引：0
|
作者：
Preljevic, V. T. [1 ]
Osthus, T. H. [2 ]
Bringager, Ch B. [1 ]
Nordhus, I. H.
Os, I [2 ]
Dammen, T. [1 ]
机构：
[1] Univ Oslo Hosp, Dept Psychiat, Ulleval, Norway
[2] Univ Oslo Hosp, Dept Nephrol, Ulleval, Norway
来源：
JOURNAL OF PSYCHOSOMATIC RESEARCH | 2009年 / 66卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
66
引用
收藏
页码：574 / 575
页数：2
相关论文
共 50 条
  • [1] Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis
    Bianchi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 105 - 110
  • [2] Abnormal lipoprotein metabolism in peritoneal dialysis (PD) compared with haemodialysis (HD) in patients with end-stage renal failure (ESRF)
    Deighan, C
    Caslake, M
    McConnell, M
    Boulton-Jones, JM
    Packard, C
    ATHEROSCLEROSIS, 1998, 141 (01) : 187 - 187
  • [3] CARDIAC DISEASE IN END-STAGE RENAL-DISEASE - A COMPARISON OF HEMODIALYSIS (HD) AND PERITONEAL-DIALYSIS (PD)
    HARNETT, JD
    KENT, G
    FOLEY, R
    MURRAY, D
    BARRE, P
    PARFREY, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 532 - 532
  • [4] Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore
    Yang, Fan
    Lau, Titus
    Luo, Nan
    NEPHROLOGY, 2016, 21 (08) : 669 - 677
  • [5] Vitamin B12 and holotranscobalamin levels in patients with end stage renal disease (ESRD), hemo (HD) or peritoneal dialysis (PD)
    De Vecchi, Amedeo F.
    Novembrino, Cristina
    Bamonti, Fabrizia
    Lonati, Silvia
    Cerutti, Roberta
    Guerra, Luisella
    Messa, Piergiorgio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 341 - 341
  • [6] Peritoneal dialysis or haemodialysis in end-stage renal disease: do registry data matter?
    Combe, Christian
    Rigothier, Claire
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (01) : 6 - 7
  • [7] Pheochromocytoma in end-stage renal disease patient treated by peritoneal dialysis
    Gorsane, Imen
    Zouaghi, Karim
    Goucha, Rim
    Bacha, Mohamed Mongi
    Hedri, Hafedh
    Khiari, Karima
    Abderrahim, Ezzedine
    Ben Abdallah, Taieb
    Ben Abdallah, Nejib
    Ben Moussa, Fatma
    Ben Maiz, Hedi
    Kheder, Adel
    NEPHROLOGIE & THERAPEUTIQUE, 2008, 4 (07): : 597 - 601
  • [8] THE INCIDENCE OF DYSLIPOPROTEINEMIA IS INCREASED IN CHILDREN WITH END-STAGE RENAL-DISEASE (ESRD) TREATED WITH PERITONEAL-DIALYSIS (PD) VERSUS HEMODIALYSIS (HD)
    HEILICZER, JD
    KUIZON, BD
    OSORIO, MA
    CLARDY, CW
    PEDIATRIC RESEARCH, 1994, 35 (04) : A366 - A366
  • [9] Peritoneal metallothionein content in patients with end-stage renal disease on or not on peritoneal dialysis
    Alscher, DM
    Biegger, D
    Mettang, T
    Dunst, R
    Wolken, D
    Kuhlmann, U
    Fritz, P
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (01): : 92 - 94
  • [10] Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis
    Filiopoulos, Vassilis
    Hadjiyannakos, Dimitrios
    Takouli, Lambrini
    Metaxaki, Polixeni
    Sideris, Vasilis
    Vlassopoulos, Dimosthenis
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (12): : 872 - 882
12345